ScholarLens Back to search
2020•mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich)Requires access

Benefit of eculizumab for a broad range of patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from prevent

Kazuo Fujihara, Achim Berthele, H J Kim, Miles J Levy, Ichiro Nakashima, Celia Oreja‐Guevara, Jacqueline A. Palace, S J Pittock, Menderes Yusuf Terzi, Natalia A. Totolyan, S Viswanathan, Wang Kc, Andrea Pace, Marcus Yountz, Larisa Miller, Imran Tanvir, R Armstrong, Dean M. Wingerchuk

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Neuromyelitis optica, Eculizumab, Spectrum disorder, Multiple sclerosis, Medicine, Aquaporin 4, Broad spectrum, Antibody

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Benefit of eculizumab for a broad range of patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from prevent — Research Paper | ScholarLens